Literature DB >> 11317656

The role of viruses in type I diabetes: two distinct cellular and molecular pathogenic mechanisms of virus-induced diabetes in animals.

H S Jun1, J W Yoon.   

Abstract

Type I (insulin-dependent) diabetes mellitus results from the progressive loss of pancreatic beta cells. Environmental factors are believed to play an important part in the development of Type I diabetes by influencing the penetrance of diabetes susceptibility genes. As one environmental factor, the virus has long been considered to play a part in this disease. To date 13 different viruses have been reported to be associated with the development of Type I diabetes in humans and in various animal models. The most clear and unequivocal evidence that a virus induces diabetes in animals comes from studies on the D variant of the encephalomyocarditis (EMC-D) virus in mice and the Kilham rat virus (KRV) in rats. The infection of genetically susceptible strains of mice with a high titre of EMC-D virus results in the development of diabetes within 3 days. This is largely due to the rapid destruction of beta cells by the replication of the virus within the beta cells. In contrast, the infection of mice with a low titre of EMC-D virus results in a limited replication of the virus before the induction of neutralizing anti-virus antibody and the subsequent recruitment of activated macrophages. The Src kinases, particularly hck, play an important part in the activation of macrophages and the subsequent production of tumour necrosis factor (TNF)-alpha, interleukin (IL)-1 beta and nitric oxide (NO), leading to the destruction of beta cells which results in the development of diabetes. The Kilham rat virus causes autoimmune diabetes in diabetes resistant (DR)-BB rats without infection of beta cells. The infection of DR-BB rats with KRV results in the disruption of the finely tuned immune balance of Th1-like CD45RC+CD4+ and Th2-like CD45RC-CD4+ T cells, leading to the selective activation of beta-cell-cytotoxic effector T cells.

Entities:  

Mesh:

Year:  2001        PMID: 11317656     DOI: 10.1007/s001250051614

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  26 in total

1.  Autoimmune type 1 diabetes: resolved and unresolved issues.

Authors:  A L Notkins; A Lernmark
Journal:  J Clin Invest       Date:  2001-11       Impact factor: 14.808

Review 2.  Toxic type 1 diabetes.

Authors:  Mark A Myers; Ian R Mackay; Paul Z Zimmet
Journal:  Rev Endocr Metab Disord       Date:  2003-09       Impact factor: 6.514

3.  Haptoglobin as an early serum biomarker of virus-induced autoimmune type 1 diabetes in biobreeding diabetes resistant and LEW1.WR1 rats.

Authors:  Annie J Kruger; Chaoxing Yang; Sun W Tam; Douglas Hinerfeld; James E Evans; Karin M Green; John Leszyk; Kejian Yang; Dennis L Guberski; John P Mordes; Dale L Greiner; Aldo A Rossini; Rita Bortell
Journal:  Exp Biol Med (Maywood)       Date:  2010-11

4.  Pathogenesis of fulminant type 1 diabetes.

Authors:  Akihisa Imagawa; Toshiaki Hanafusa
Journal:  Rev Diabet Stud       Date:  2007-02-10

Review 5.  Targeting Innate Immunity for Type 1 Diabetes Prevention.

Authors:  James C Needell; Danny Zipris
Journal:  Curr Diab Rep       Date:  2017-09-27       Impact factor: 4.810

6.  High titres of IgA antibodies to enterovirus in fulminant type-1 diabetes.

Authors:  A Imagawa; T Hanafusa; H Makino; J-I Miyagawa; P Juto
Journal:  Diabetologia       Date:  2005-01-15       Impact factor: 10.122

7.  Caspase-3-dependent beta-cell apoptosis in the initiation of autoimmune diabetes mellitus.

Authors:  Nicole Liadis; Kiichi Murakami; Mohamed Eweida; Alisha R Elford; Laura Sheu; Herbert Y Gaisano; Razqallah Hakem; Pamela S Ohashi; Minna Woo
Journal:  Mol Cell Biol       Date:  2005-05       Impact factor: 4.272

8.  Prenatal viral exposure followed by adult stress produces glucose intolerance in a mouse model.

Authors:  B Niklasson; A Samsioe; M Blixt; S Sandler; A Sjöholm; E Lagerquist; A Lernmark; W Klitz
Journal:  Diabetologia       Date:  2006-07-05       Impact factor: 10.122

9.  T lymphocyte response against pancreatic beta cell antigens in fulminant Type 1 diabetes.

Authors:  R Kotani; M Nagata; A Imagawa; H Moriyama; H Yasuda; J Miyagawa; T Hanafusa; K Yokono
Journal:  Diabetologia       Date:  2004-07-09       Impact factor: 10.122

10.  Role of nitric oxide in the pathogenesis of encephalomyocarditis virus-induced diabetes in mice.

Authors:  Young-Sun Lee; Na Li; Seungjin Shin; Hee-Sook Jun
Journal:  J Virol       Date:  2009-06-17       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.